Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q1 2014 · 10-Q
Revenue$3.90B$3.90B+22.3% vs Q1 2013 Net Income$543.10M$543.10M+61.5% vs Q1 2013 EPS Diluted$1.36$1.36+46.2% vs Q1 2013 Gross Profit$1,620,000,000+21.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flow$101,200,000−66.1% Free Cash Flowderived-$3,500,000N/M Margins · derivedGross margin41.5%−0.4 pt vs Q1 2013
Operating margin22.4%+10.3 pt vs Q1 2013
Net margin13.9%+3.4 pt vs Q1 2013
ended Mar 29, 2014 · filed May 2, 2014 · 34 d after period end